IonQ, Inc. — Q1 2023 Form 10-Q
Reporting period: Three months ended March 31, 2023; figures are unaudited. Unless otherwise stated, financial amounts are in U.S. dollars. IonQ develops trapped-ion quantum computing systems and provides quantum-computing-as-a-service (QCaaS), consulting, and specialized system contracts. It reported as one operating segment.
Financial performance and position
| Metric | Q1 2023 | Q1 2022 or comparison |
|---|---|---|
| Revenue | $4.3 million | $2.0 million; up 119%, primarily from new service contracts |
| Cost of revenue, excluding depreciation and amortization | $1.0 million | $0.6 million |
| Gross margin, using the above cost of revenue | Approximately 76% | Approximately 71% |
| Research and development | $16.2 million | $7.3 million; up 121% |
| Sales and marketing | $2.7 million | $1.9 million |
| General and administrative | $10.6 million | $9.2 million |
| Operating loss | $28.0 million | $18.3 million |
| Net loss | $27.3 million; $0.14 per share | $4.2 million; $0.02 per share |
| Operating cash flow | $(13.8) million | $(8.3) million |
| Cash, cash equivalents and investments | $525.5 million, excluding $2.0 million restricted cash | — |
Gross margin is an approximate calculation from reported revenue less cost of revenue; it excludes depreciation and amortization, which is presented separately. Interest income was $4.2 million, versus $0.6 million a year earlier. The warrant-liability fair-value change was a $3.6 million loss, compared with a $13.4 million gain in Q1 2022; these non-operating swings materially affect year-over-year net loss comparisons.
At March 31, 2023, total assets were $587.9 million, total liabilities $35.7 million, and stockholders’ equity $552.2 million. The filing reports no borrowings or other debt balance; operating lease liabilities were $6.2 million, with total undiscounted lease payments of $15.9 million. Current assets were $402.3 million and current liabilities $20.9 million. Accumulated deficit was $221.6 million. Cash, cash equivalents and restricted cash at quarter-end totaled $53.9 million, including $2.0 million restricted.
Changes, outlook and key commentary
- Operating expenses rose as IonQ expanded research and development and headcount. R&D payroll-related costs increased $7.7 million, including higher stock-based compensation; total stock-based compensation expense, net of amounts capitalized, was $10.3 million.
- Management said liquidity at quarter-end was expected to fund working capital and capital expenditure needs for the next 12 months. It expects significant losses and higher operating expenses to continue; the filing provides no specific numerical full-year 2023 revenue or earnings guidance.
- Management described IonQ as early in its commercial growth and said profitability depends on successful development and commercialization. The filing states that significant production and delivery of quantum computers is not expected before 2025 at the earliest, and may occur later or never.
- Reported technical and commercial developments included achieving 29 algorithmic qubits on IonQ Forte—described as seven months ahead of the 2023 technical roadmap—and completing construction of IonQ Aria 2. These are company-reported milestones, not financial results.
- Remaining performance obligations were approximately $30.4 million, including funded and unfunded orders; IonQ expects about 60% to be recognized within 12 months. Three customers each represented more than 10% of Q1 revenue; individual customer percentages were not provided in the supplied filing text.
- Revenue was concentrated in the United States (approximately 86%). Management cited inflation, interest rates, supply-chain constraints, employee costs, and potential financing access as risks. It also disclosed that deposits held at Silicon Valley Bank were exposed to limited risk before authorities resolved the bank in a manner that protected depositors.
- A consolidated securities class action seeks damages; defendants moved to dismiss, and the company said it could not reasonably estimate a possible loss. IonQ also disclosed a separate dMY-related litigation matter, for which management did not expect a material adverse effect. In March 2023, the Delaware Court of Chancery granted IonQ’s petition validating its amended certificate of incorporation and shares issued in reliance on it.
Important facts for investors to verify
- Whether revenue growth converts into recurring customer demand, and the timing and funding status of the $30.4 million remaining performance obligations.
- Progress toward technical and manufacturing milestones, including whether reported qubit performance translates into commercially useful, scalable systems.
- Operating cash burn, investment portfolio liquidity and interest-rate exposure; management’s 12-month liquidity assessment depends on internal projections and changing business conditions.
- The effects of customer concentration, rising R&D and personnel costs, and substantial stock-based compensation on future margins and dilution.
- Developments in the securities class action and any related financial exposure; the filing provides no estimable loss range.